Biolase's market cap is currently ―. The company's EPS TTM is $-38.014; its P/E ratio is >-0.01; Biolase is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $-0.17. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Mar 23	Dec 22	Sep 22	Jun 22
Income Statement	-
Total Revenue	$ 10.92M	$ 10.47M	$ 14.05M	$ 12.01M	$ 12.23M
Gross Profit	$ 3.75M	$ 3.34M	$ 3.60M	$ 2.44M	$ 5.14M
EBIT	$ -3.97M	$ -6.45M	$ -8.36M	$ -7.98M	$ -5.16M
EBITDA	$ -3.31M	$ -6.19M	$ -7.23M	$ -7.86M	$ -5.03M
Net Income Common Stockholders	$ -4.59M	$ -5.85M	$ -9.43M	$ -8.39M	$ -5.61M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 7.81M	$ 6.50M	$ 4.18M	$ 9.96M	$ 19.55M
Total Assets	$ 38.74M	$ 41.94M	$ 38.19M	$ 42.87M	$ 50.85M
Total Debt	$ 15.10M	$ 15.33M	$ 15.05M	$ 14.84M	$ 14.91M
Net Debt	$ 7.29M	$ 8.83M	$ 10.87M	$ 4.88M	$ -4.64M
Total Liabilities	$ 32.86M	$ 33.79M	$ 33.30M	$ 29.01M	$ 29.24M
Stockholders Equity	$ 332.00K	$ 8.16M	$ 4.89M	$ 13.86M	$ 21.61M
Cash Flow	-
Free Cash Flow	$ -2.77M	$ -6.25M	$ -6.07M	$ -9.22M	$ -6.89M
Operating Cash Flow	$ -2.59M	$ -5.66M	$ -5.60M	$ -6.55M	$ -6.61M
Investing Cash Flow	$ -182.00K	$ -587.00K	$ -444.00K	$ -2.68M	$ -274.00K
Financing Cash Flow	$ 3.76M	$ 8.51M	$ -32.00K	$ -214.00K	$ 4.85M

Currency in USD

Biolase Earnings and Revenue History

Income Statement >

Biolase Debt to Assets

Balance Sheet >

Biolase Cash Flow

Cash Flow >

Biolase Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing